{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:43:41Z","timestamp":1768279421590,"version":"3.49.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","progcardvascdis.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.pcad.2015.11.003","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T11:57:49Z","timestamp":1447156669000},"page":"514-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Treatment of Depression in Patients with Concomitant Cardiac Disease"],"prefix":"10.1016","volume":"58","author":[{"given":"Robyn M.","family":"Teply","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Packard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole D.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Hilleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"DiNicolantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pcad.2015.11.003_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0006-3223(03)00568-7","article-title":"Depression and cardiovascular disease: mechanisms of interaction","volume":"54","author":"Joynt","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.pcad.2015.11.003_bb0015","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","article-title":"Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations","volume":"129","author":"Lichtman","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2015.11.003_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ahj.2007.03.043","article-title":"Relationship between depressive symptoms and long-term mortality in patients with heart failure","volume":"154","author":"Jiang","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2015.11.003_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejheart.2004.05.011","article-title":"Depression increasingly predicts mortality in the course of congestive heart failure","volume":"7","author":"Junger","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2015.11.003_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.PSY.0000038938.67401.85","article-title":"Prevalence of depression in hospitalized patients with congestive heart failure","volume":"65","author":"Freedland","year":"2003","journal-title":"Psychosom Med"},{"issue":"6","key":"10.1016\/j.pcad.2015.11.003_bb0035","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1592\/phco.23.6.754.32185","article-title":"Safety of antidepressant drugs in the patient with cardiac disease: a review of the literature","volume":"23","author":"Alvarez","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pcad.2015.11.003_bb0040","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0002-9149(01)01562-4","article-title":"Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease","volume":"87","author":"Serebruany","year":"2001","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2015.11.003_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4088\/JCP.09m05853blu","article-title":"Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial","volume":"72","author":"Hummel","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pcad.2015.11.003_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1753944708096282","article-title":"Electrophysiological changes of cardiac function during antidepressant treatment","volume":"3","author":"Sala","year":"2009","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2015.11.003_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00131746-200311000-00004","article-title":"Cardiovascular health and depression","volume":"9","author":"Glassman","year":"2003","journal-title":"J Psychiatr Pract"},{"issue":"4","key":"10.1016\/j.pcad.2015.11.003_bb0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.279.4.287","article-title":"Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease","volume":"270","author":"Roose","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2015.11.003_bb0065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1176\/ajp.156.7.1024","article-title":"Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease","volume":"156","author":"Nelson","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.pcad.2015.11.003_bb0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/oby.2002.142","article-title":"Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms","volume":"10","author":"Jain","year":"2002","journal-title":"Obes Res"},{"issue":"10","key":"10.1016\/j.pcad.2015.11.003_bb0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/oby.2002.86","article-title":"Bupropion SR enhances weight loss: a 48week double-blind, placebo controlled trial","volume":"7","author":"Anderson","year":"2002","journal-title":"Obes Res"},{"issue":"5","key":"10.1016\/j.pcad.2015.11.003_bb0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.psy.45.5.371","article-title":"Tricyclic antidepressants, QT interval prolongation, and torsade de pointes","volume":"45","author":"Vieweg","year":"2004","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.pcad.2015.11.003_bb0085","first-page":"35","article-title":"Factors related to orthostatic hypotension associated with tricyclic antidepressants","volume":"43","author":"Glassman","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1987.01800150093011","article-title":"Tricyclic antidepressants in depressed patients with cardiac conduction disease","volume":"44","author":"Roose","year":"1987","journal-title":"Arch Gen Psychiatry"},{"issue":"2, Suppl.","key":"10.1016\/j.pcad.2015.11.003_bb0095","first-page":"16","article-title":"Review of the cardiovascular effects of heterocyclic antidepressants","volume":"54","author":"Glassman","year":"1993","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pcad.2015.11.003_bb0100","first-page":"145","article-title":"Metabolic and physiologic consequences of nortriptyline treatment in the elderly","volume":"30","author":"Pollock","year":"1994","journal-title":"Psychopharmacol Bull"},{"issue":"40","key":"10.1016\/j.pcad.2015.11.003_bb0105","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0006-3223(95)00599-4","article-title":"Serum lipid concentrations in patients with major depressive disorder","volume":"11","author":"Olusi","year":"1996","journal-title":"Biol Psychiatry"},{"issue":"24","key":"10.1016\/j.pcad.2015.11.003_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.jcp.0000138762.23482.63","article-title":"Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment","volume":"5","author":"Kopf","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pcad.2015.11.003_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2165\/00002018-199410010-00003","article-title":"Comparative tolerability profiles of the newer versus older antidepressants","volume":"10","author":"Rudorfer","year":"1994","journal-title":"Drug Saf"},{"issue":"10","key":"10.1016\/j.pcad.2015.11.003_bb0120","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","article-title":"Antidepressants and body weight: a comprehensive review and meta-analysis","volume":"71","author":"Serretti","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0125","series-title":"Lexi-Drugs Online","author":"Lexicomp Online","year":"2014"},{"issue":"64","key":"10.1016\/j.pcad.2015.11.003_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments","volume":"1","author":"Bilici","year":"2001","journal-title":"J Affect Disord"},{"issue":"36","key":"10.1016\/j.pcad.2015.11.003_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arcmed.2004.12.018","article-title":"Comparison of fluoxetine and paroxetine in Type II diabetes mellitus patients","volume":"2","author":"Gulseren","year":"2005","journal-title":"Arch Med Res"},{"issue":"1","key":"10.1016\/j.pcad.2015.11.003_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000079172.43229.CD","article-title":"Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction","volume":"108","author":"Sauer","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pcad.2015.11.003_bb0145","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/oby.2002.142","article-title":"Bupropion SR versus placebo for weight loss in obese patients with depressive symptoms","volume":"10","author":"Jain","year":"2002","journal-title":"Obes Res"},{"issue":"3","key":"10.1016\/j.pcad.2015.11.003_bb0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4088\/JCP.v67n0313","article-title":"Effect of mirtazapine treatment on body composition and metabolism","volume":"67","author":"Laimer","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.pcad.2015.11.003_bb0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4088\/JCP.v64n0805","article-title":"The effects of mirtazapine on plasma lipid profiles in healthy subjects","volume":"64","author":"Nicholas","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004714-200702000-00005","article-title":"Comparison of duloxetine, escitalopram and sertraline effects on cytochrome P450 2D6 function in healthy volunteers","volume":"27","author":"Preskorn","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/j.1875-9114.1997.tb03691.x","article-title":"Warfarin-fluoxetine and diazepam-fluoxetine interaction","volume":"17","author":"Dent","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pcad.2015.11.003_bb0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-198632040-00002","article-title":"Fluvoxamine: a review of its pharamcodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness","volume":"32","author":"Benfield","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.pcad.2015.11.003_bb0175","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0140-6736(93)91265-N","article-title":"Interaction of metoprolol and fluoxetine","volume":"341","author":"Walley","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2015.11.003_bb0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(94)91265-3","article-title":"Heart block in a patient on propranolol and fluoxetine","volume":"343","author":"Drake","year":"1994","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pcad.2015.11.003_bb0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/B:CARD.0000041254.15807.98","article-title":"Severe sinus bradycardia after initiation of bupropion therapy: a probable drug-drug interaction with metoprolol","volume":"18","author":"McCollum","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2015.11.003_bb0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004714-199112000-00019","article-title":"Fluoxetine-associated potentiation of calcium-channel blockers","volume":"11","author":"Sternbach","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0195","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0009-9236(99)70015-9","article-title":"Fluoxetine impairs the CYP2D6-mediate metabolism of propafenone enantiomers in healthy Chinese volunteers","volume":"66","author":"Cai","year":"1999","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pcad.2015.11.003_bb0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/phar.1542","article-title":"Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial","volume":"35","author":"Hirsh-Rokach","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pcad.2015.11.003_bb0205","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archpsyc.65.7.795","article-title":"Risk of upper gastrointestinal tract bleedings associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents","volume":"65","author":"De Abajo","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJMc062840","article-title":"Hyponatremia associated with escitalopram","volume":"356","author":"Covyeou","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0215","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1592\/phco.20.5.476.35061","article-title":"Hypertensive urgency induced by an interaction of mirtazapine and clonidine","volume":"20","author":"Abo-Zena","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pcad.2015.11.003_bb0220","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/bja\/aep034","article-title":"Interaction between clonidine and escitalopram","volume":"102","author":"Nikolic","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pcad.2015.11.003_bb0225","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/07853890903186168","article-title":"The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients","volume":"41","author":"Hauta-Aho","year":"2009","journal-title":"Ann Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.HYP.0000200688.37802.01","article-title":"Blood pressure reactivity to psychological stress: a new risk factor for coronary disease?","volume":"47","author":"Williams","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2015.11.003_bb0235","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.126698","article-title":"Depression is associated with decreased blood pressure, but antidepressant use increases risk for hypertension","volume":"52","author":"Licht","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2015.11.003_bb0240","first-page":"574","article-title":"Cardiovascular safety in depressed patients: focus on venlafaxine","volume":"56","author":"Feighner","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0245","first-page":"338","article-title":"Is doxepin a safer \u2018bicyclic\u2019 for the heart?","volume":"52","author":"Roose","year":"1991","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pcad.2015.11.003_bb0250","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/10401239409148989","article-title":"The cardiovascular effects of bupropion and nortriptyline in depressed outpatients","volume":"6","author":"Kiev","year":"1994","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0255","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archinte.1995.00430050022003","article-title":"High blood pressure: a side effect of drugs, poisons, and foods","volume":"155","author":"Grossman","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0260","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.282.6.539","article-title":"Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators","volume":"282","author":"Staessen","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2015.11.003_bb0265","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0002-9149(03)00286-8","article-title":"Effect of nortriptyline on the day-night systolic blood pressure difference in hypertensive and normotensive elderly depressed women","volume":"19","author":"Scalco","year":"2003","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2015.11.003_bb0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/070674371005500205","article-title":"Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis","volume":"55","author":"Dowlati","year":"2010","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0275","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00006842-198811000-00009","article-title":"Major depressive disorder predicts cardiac events in patients with coronary artery disease","volume":"50","author":"Carney","year":"1988","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0280","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-199307000-00003","article-title":"Depressed effect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults","volume":"4","author":"Anda","year":"1993","journal-title":"Epidemiology"},{"key":"10.1016\/j.pcad.2015.11.003_bb0285","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9149(01)01675-7","article-title":"Even minimal symptoms of depression increase mortality risk after acute myocardial infarction","volume":"88","author":"Bush","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.PSY.0000058371.50240.E3","article-title":"Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review","volume":"65","author":"Wulsin","year":"2003","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0295","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1176\/appi.ajp.2007.06091492","article-title":"Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events","volume":"164","author":"De Jonge","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.pcad.2015.11.003_bb0300","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2012.04.040","article-title":"Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study","volume":"60","author":"Blumenthal","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0305","first-page":"83","article-title":"Antidepressant choice in the patient with cardiac disease: lessons from the cardiac arrhythmia suppression trial (CAST) studies","volume":"55","author":"Roose","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 5","key":"10.1016\/j.pcad.2015.11.003_bb0310","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00004850-199809005-00006","article-title":"Cardiovascular effects of antidepressant drugs: updated","volume":"13","author":"Glassman","year":"1998","journal-title":"Int J Clin Psychopharmacol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0315","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.108.190769","volume":"118","author":"Lichtman","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pcad.2015.11.003_bb0320","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1176\/ajp.139.9.1114","article-title":"Cardiovascular and antidepressant effects of imipramine in the treatment of secondary depression in patients with ischemic heart disease","volume":"139","author":"Raskind","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0325","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJM198204223061603","article-title":"Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease","volume":"306","author":"Veith","year":"1982","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pcad.2015.11.003_bb0330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0033-3182(85)72885-X","article-title":"Major depression in patients with cardiac disease: diagnosis and somatic treatment","volume":"26","author":"Levenson","year":"1985","journal-title":"Psychosomatics"},{"key":"10.1016\/j.pcad.2015.11.003_bb0335","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/eurheartj\/ehq438","article-title":"Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey","volume":"32","author":"Hamer","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2015.11.003_bb0340","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00006842-200011000-00007","article-title":"Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial","volume":"62","author":"Strik","year":"2000","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1745-0179-1-26","article-title":"Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome","volume":"1","author":"Mohapatra","year":"2005","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"10.1016\/j.pcad.2015.11.003_bb0350","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004850-199811000-00004","article-title":"Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients","volume":"13","author":"Strik","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.pcad.2015.11.003_bb0355","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina (the SADHART Trial)","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pcad.2015.11.003_bb0360","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.297.4.367","article-title":"Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. The Canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (CREATE) trial","volume":"297","author":"Lesperance","year":"2007","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.pcad.2015.11.003_bb0365","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.289.23.3106","article-title":"Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial","volume":"289","author":"Berkman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2015.11.003_bb0370","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archpsyc.62.7.792","article-title":"Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction","volume":"62","author":"Taylor","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0375","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/FJC.0b013e3182677041","article-title":"Cardiovascular safety of one-year escitalopram therapy in clinically nondepressed patients with acute coronary syndrome: results from the depression in patients with coronary artery disease (DECARD) trial","volume":"60","author":"Hanash","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0380","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.amjcard.2010.11.017","article-title":"Meta-analysis of selective serotonin reuptake inhibitors in patients with depression and coronary heart disease","volume":"107","author":"Pizzi","year":"2011","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2015.11.003_bb0385","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mhj.2001.116766","article-title":"Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction","volume":"142","author":"McFarlane","year":"2001","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.pcad.2015.11.003_bb0390","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archpsyc.64.9.1025","article-title":"Heart rate variability in acute coronary syndrome patients with major depression","volume":"64","author":"Glassman","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0395","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(02)01394-X","article-title":"Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures","volume":"52","author":"Yeragani","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.pcad.2015.11.003_bb0400","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/clpt.2009.121","article-title":"Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease","volume":"86","author":"Pizzi","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"20","key":"10.1016\/j.pcad.2015.11.003_bb0405","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1001\/jama.2013.5566","article-title":"Effect of escitalopram on mental stress-induced myocardial ischemia","volume":"309","author":"Jiang","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2015.11.003_bb0410","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.PSY.0000088596.42029.10","article-title":"Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?","volume":"65","author":"Schins","year":"2003","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0415","first-page":"e000544","article-title":"Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants","volume":"2","author":"Castro","year":"2012","journal-title":"Br Med J Open"},{"issue":"6","key":"10.1016\/j.pcad.2015.11.003_bb0420","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1503\/cmaj.100912","article-title":"Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction","volume":"183","author":"Labos","year":"2011","journal-title":"Can Med Assoc J"},{"issue":"12","key":"10.1016\/j.pcad.2015.11.003_bb0425","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4088\/JCP.09r05786blu","article-title":"Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms","volume":"71","author":"Andrade","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"24","key":"10.1016\/j.pcad.2015.11.003_bb0430","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.295.24.2874","article-title":"Depression and cardiovascular disease","volume":"295","author":"Whooley","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2015.11.003_bb0435","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10865-009-9218-3","article-title":"The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients","volume":"32","author":"Gravely-Witte","year":"2009","journal-title":"J Behav Med"},{"issue":"4","key":"10.1016\/j.pcad.2015.11.003_bb0440","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2125.2003.01890.x","article-title":"Chest pain during use of bupropion as an aid in smoking cessation","volume":"56","author":"DeGraaf","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.pcad.2015.11.003_bb0445","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.amjmed.2006.04.024","article-title":"Bupropion for smokers hospitalized with acute cardiovascular disease","volume":"119","author":"Rigotti","year":"2006","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.pcad.2015.11.003_bb0450","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicenter randomized study","volume":"24","author":"Tonstad","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2015.11.003_bb0455","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PSY.0b013e31814b260d","article-title":"Treatment of post-myocardial infarction depressive disorder: a randomized, placebo controlled trial with mirtazapine","volume":"69","author":"Honig","year":"2007","journal-title":"Psychosom Med"},{"issue":"9","key":"10.1016\/j.pcad.2015.11.003_bb0460","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/01.JGP.0000204328.50105.b3","article-title":"Cardiovascular changes associated with venlafaxine in the treatment of late-life depression","volume":"14","author":"Johnson","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0465","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0006-3223(03)00320-2","article-title":"Treatment of depression in patients with heart disease","volume":"54","author":"Roose","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.pcad.2015.11.003_bb0470","doi-asserted-by":"crossref","first-page":"e79109","DOI":"10.1371\/journal.pone.0079109","article-title":"Depression in atrial fibrillation in the general population","volume":"8","author":"Schnabel","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pcad.2015.11.003_bb0475","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/pace.12292","article-title":"The effect of anxiety and depression on symptoms attributed to atrial fibrillation","volume":"37","author":"Thompson","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0480","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jacc.2008.10.060","article-title":"Depression and risk of sudden cardiac death and coronary heart disease in women. Results from the Nurses' Health Study","volume":"53","author":"Whang","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0485","author":"Credible Meds"},{"issue":"5","key":"10.1016\/j.pcad.2015.11.003_bb0490","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2125.2009.03496.x","article-title":"Sudden death in patients receiving drugs tending to prolong the QT interval","volume":"68","author":"Jolly","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.f288","article-title":"QT interval and antidepressant use: a cross-sectional study of electronic health records","volume":"346","author":"Castro","year":"2013","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.pcad.2015.11.003_bb0505","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4088\/JCP.13r08672","article-title":"Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation","volume":"75","author":"Beach","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.pcad.2015.11.003_bb0510","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1176\/appi.ajp.2013.12030408","article-title":"Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40mg","volume":"170","author":"Zivan","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0515","author":"Medicines and Healthcare Products Regulatory Agency (MHRA)"},{"key":"10.1016\/j.pcad.2015.11.003_bb0520","series-title":"Highlights of Lexapro\u00ae Prescribing Information","author":"Forest Laboratories","year":"2012"},{"key":"10.1016\/j.pcad.2015.11.003_bb0525","first-page":"174","article-title":"Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease","volume":"52","author":"Buff","year":"1991","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.pcad.2015.11.003_bb0530","first-page":"385","article-title":"Fluoxetine-induced bradycardia and syncope in two patients","volume":"51","author":"Ellison","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0535","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1176\/appi.ajp.163.2.325","article-title":"QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine [letter]","volume":"163","author":"Wilting","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.pcad.2015.11.003_bb0540","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1060028013501994","article-title":"A comparison of the risk of QT prolongation among SSRIs","volume":"47","author":"Funk","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pcad.2015.11.003_bb0545","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/cap.2008.0136","article-title":"Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy","volume":"10","author":"Brzozowska","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0550","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00228-011-1091-7","article-title":"Clinical impact of fluvoxamine-mediated long QT syndrome","volume":"68","author":"Nia","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.pcad.2015.11.003_bb0555","first-page":"164","article-title":"A double-blind, placebo-controlled dose-finding study with sertraline","volume":"25","author":"Amin","year":"1989","journal-title":"Psychopharmacol Bull"},{"issue":"Suppl. 2","key":"10.1016\/j.pcad.2015.11.003_bb0560","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000284093","article-title":"The role of trazodone in the treatment of depressed cardiac patients","volume":"17","author":"Himmelhoch","year":"1984","journal-title":"Psychopathology"},{"issue":"6","key":"10.1016\/j.pcad.2015.11.003_bb0565","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1176\/ajp.140.6.796","article-title":"Ventricular arrhythmias possibly aggravated by trazodone","volume":"140","author":"Janowsky","year":"1983","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.pcad.2015.11.003_bb0570","first-page":"388","article-title":"A case of trazodone-induced ventricular tachycardia","volume":"47","author":"Aronson","year":"1986","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pcad.2015.11.003_bb0575","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1378\/chest.98.1.247","article-title":"Trazodone-related exercise-induced nonsustained ventricular tachycardia","volume":"98","author":"Vitullo","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.pcad.2015.11.003_bb0580","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0167-5273(95)02435-Y","article-title":"QT prolongation and polymorphous ventricular tachycardia with trazodone-amiodarone combination","volume":"52","author":"Mazur","year":"1995","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0585","doi-asserted-by":"crossref","first-page":"969a","DOI":"10.1176\/ajp.156.6.969a","article-title":"Prolonged QT interval after trazodone overdose","volume":"156","author":"Levenson","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.pcad.2015.11.003_bb0590","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00004714-198612000-00022","article-title":"Effects of trazodone and desipramine on cardiac rate and rhythm in a patient with preexisting cardiovascular disease","volume":"6","author":"Pohl","year":"1986","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0595","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00605991","article-title":"The electrocardiographic and anticholinergic effects of trazodone and imipramine in man","volume":"23","author":"Burgess","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.pcad.2015.11.003_bb0600","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijcard.2005.03.065","article-title":"QT interval prolongation associated with venlafaxine administration","volume":"109","author":"Letsas","year":"2006","journal-title":"Int J Cardiol"},{"issue":"5-6","key":"10.1016\/j.pcad.2015.11.003_bb0605","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00508-013-0330-6","article-title":"Duloxetine-induced life-threatening long AT syndrome","volume":"125","author":"Stuhec","year":"2013","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"10.1016\/j.pcad.2015.11.003_bb0610","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-200730050-00007","article-title":"An evaluation of the cardiovascular safety profile of duloxetine. Findings from 42 placebo-controlled studies","volume":"30","author":"Wernicke","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.pcad.2015.11.003_bb0615","author":"Health Canada"},{"issue":"8","key":"10.1016\/j.pcad.2015.11.003_bb0620","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1592\/phco.24.11.1095.36134","article-title":"Elevated defibrillation threshold with venlafaxine therapy","volume":"24","author":"Carnes","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pcad.2015.11.003_bb0625","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00005344-198101000-00009","article-title":"Electrophysiological effects of antidepressants on mammalian hearts and crayfish giant axon","volume":"3","author":"Wang","year":"1981","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0630","first-page":"311","article-title":"Amitriptyline and heart block","volume":"3","author":"Smith","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.pcad.2015.11.003_bb0635","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jama.1975.03240250034022","article-title":"Imipramine-induced heart block: a longitudinal case study","volume":"231","author":"Kantor","year":"1975","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pcad.2015.11.003_bb0640","first-page":"65","article-title":"The effect of nortriptyline in elderly patients with cardiac conduction disease","volume":"51","author":"Dietch","year":"1990","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.pcad.2015.11.003_bb0645","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00019442-200510000-00013","article-title":"Atrioventricular blocks associated with citalopram","volume":"13","author":"Gambassi","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0650","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1345\/aph.1A136","article-title":"Citalopram-induced bradycardia and presyncope","volume":"35","author":"Isbister","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pcad.2015.11.003_bb0655","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hup.746","article-title":"Trazodone-induced cardiac arrhythmias: a report of two cases","volume":"21","author":"Winkler","year":"2006","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"7","key":"10.1016\/j.pcad.2015.11.003_bb0660","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1176\/ajp.140.7.945b","article-title":"Reversible cardiac conduction abnormality associated with trazodone administration","volume":"140","author":"Irwin","year":"1983","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0665","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.amjcard.2006.01.038","article-title":"Usefulness of paroxetine in depressed men with paroxysmal atrial fibrillation","volume":"97","author":"Shirayama","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0670","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0447.2000.102004250.x","article-title":"Psychotropic interactions with warfarin","volume":"102","author":"Sayal","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pcad.2015.11.003_bb0675","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cardfail.2003.09.008","article-title":"Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure","volume":"10","author":"Joynt","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2015.11.003_bb0680","first-page":"1849","article-title":"Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure","volume":"161","author":"Jiang","year":"2001"},{"key":"10.1016\/j.pcad.2015.11.003_bb0685","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1432-2277.2010.01056.x","article-title":"Depression disease severity as correlates of everyday physical activity in heart transplant candidates","volume":"23","author":"Spaderna","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.pcad.2015.11.003_bb0690","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/archinte.168.20.2232","article-title":"Antidepressant use, depression, and survival in patients with heart failure","volume":"168","author":"O'Connor","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0695","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11920-004-0065-1","article-title":"Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease","volume":"6","author":"Jiang","year":"2004","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pcad.2015.11.003_bb0700","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1001\/archinte.162.16.1860","article-title":"Depression-related costs in heart failure care","volume":"162","author":"Sullivan","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0705","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCHEARTFAILURE.112.000118","article-title":"Depression, healthcare utilization, and death in heart failure","volume":"6","author":"Moraska","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2015.11.003_bb0710","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cardfail.2011.12.005","article-title":"Depression predicts repeated heart failure hospitalizations","volume":"18","author":"Johnson","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2015.11.003_bb0715","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.hrtlng.2012.06.002","article-title":"Effects of interventions on depression in heart failure: a systematic review","volume":"41","author":"Woltz","year":"2012","journal-title":"Heart Lung"},{"issue":"1","key":"10.1016\/j.pcad.2015.11.003_bb0720","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10741-008-9081-2","article-title":"The use of cognitivie behavioral therapy in the treatment of depression for individuals with CHF","volume":"14","author":"O'Hea","year":"2009","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10.1016\/j.pcad.2015.11.003_bb0725","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2190\/PM.44.4.c","article-title":"Depression ratings and antidepressant use among outpatient heart failure patients: implications for the screening and treatment of depression","volume":"44","author":"Jimenez","year":"2012","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.pcad.2015.11.003_bb0730","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.hrtlng.2012.12.003","article-title":"Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain","volume":"42","author":"Chung","year":"2013","journal-title":"Heart Lung"},{"key":"10.1016\/j.pcad.2015.11.003_bb0735","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ijcard.2012.03.143","article-title":"Depression, antidepressants, and long-term mortality in heart failure","volume":"167","author":"Diez-Quevedo","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0740","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cardfail.2008.02.015","article-title":"Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression","volume":"14","author":"Tousoulis","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2015.11.003_bb0745","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCHEARTFAILURE.109.851246","article-title":"Prognosis in heart failure and the value of beta-blockers are altered by the use of antidepressants and depend on the type of antidepressant used","volume":"2","author":"Fosbol","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2015.11.003_bb0750","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2010.01.006","article-title":"High mortality among heart failure patients treated with antidepressants","volume":"146","author":"Veien","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0755","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.ejheart.2007.10.005","article-title":"Rationale and design of a randomized, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF)","volume":"9","author":"Angermann","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2015.11.003_bb0760","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2010.03.068","article-title":"Safety and efficacy of sertraline for depression in patients with heart failure","volume":"56","author":"O'Connor","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2015.11.003_bb0765","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ahj.2007.02.024","article-title":"A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure","volume":"153","author":"Gottlieb","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2015.11.003_bb0770","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/ajp.155.5.660","article-title":"Cardiovascular effects of fluoxetine in depressed patients with heart disease","volume":"155","author":"Roose","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pcad.2015.11.003_bb0775","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.1983.03340150039023","article-title":"The use of imipramine in depressed patients with congestive heart failure","volume":"250","author":"Glassman","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2015.11.003_bb0780","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/ajp.148.4.512","article-title":"Cardiovascular effects of bupropion in depressed patients with heart disease","volume":"148","author":"Roose","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"23","key":"10.1016\/j.pcad.2015.11.003_bb0785","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1001\/jama.1986.03380230077030","article-title":"Nortriptyline in depressed patients with left ventricular impairment","volume":"256","author":"Roose","year":"1986","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pcad.2015.11.003_bb0790","first-page":"114","article-title":"Antidepressant efficacy and cardiac safety of trimipramine in patients with mild heart disease","volume":"15","author":"Cohn","year":"1993","journal-title":"Clin Ther"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062015300220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062015300220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T10:24:25Z","timestamp":1718187865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062015300220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0033062015300220"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2015.11.003","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Depression in Patients with Concomitant Cardiac Disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2015.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}